Culturing ‘Unculturable’ Microbes
Functional analysis of microbes using our ultrahigh-throughput, single cell, lab-on-a-chip platform
Single bacteria in droplet encapsulation
Strain growth, assay, and strain selection
Strain isolation and growth
Novel Beneficial Strains
Biomillenia has the know-how to culture and undertake functional analysis of microbes in low volume droplets using the Company’s proprietary lab-on-a-chip platform.
A key advantage of the platform is that it maintains a higher diversity of the original microbe sample; thus enabling Biomillenia to culture previously ‘unculturable’ microbes.
With a parallel throughput several magnitudes higher than conventional methods (>30,000,000 bacteria strains per day), Biomillenia can culture and screen live strains and variants for next-generation consumer health products in volumes that to date have not been economically feasible.
Microbial strains with improved desired phenotype
- Ultra-high-throughput single cell culture and screening allows for the processing of tens of millions of variants in a single screen
- Workflows can be repeated in rapid (weeks) turnaround time
- A variety of assay capabilities allow direct selection of many desired phenotypes using non-GMO techniques
BIOMILLENIA SAS, 6 Rue Jean Calvin, IPGG building
75005 Paris, France. Tel: +33 (0)1 40 79 45 96